Sin embargo, Novo Nordisk continu investigando el potencial del GLP-1 en el manejo de la obesidad, lo que llev a la aprobacin de liraglutida para este fin en 2014
This section underscores the importance of investigating the relationship between enteric hyperoxaluria and the onset of acute kidney injury, particularly in the context of conditions such as inflammatory bowel disease, short bowel syndrome, and following bariatric surgery [75]
A., & Albrecht, T
[DOI] [PMC free article] [PubMed] [Google Scholar] 167.Ghadiri N, Javidan M, Tatan , Liao Z, Ganjalkhani-Hakemi M
Absorbance was recorded at 595 nm with a microplate reader (Tecan, Switzerland)
FDA approval timeline June 17, 2025 FDA designations: Fast Track, Orphan Drug Financial forecast (reported in millions) sepiapterin oral Manufacturer: PTC Therapeutics Proposed indications Clinical overview Mechanism of action Sepiapterin reduces phenylalanine levels in the blood via a dual mechanism of action